FindTrial
Sign In

Role of MRI and Immunotherapy test in the assessment of survival of penile cancer

Role of Multiparametric MRI without artificial erection and Programmed Death Ligand-1 expression in Preoperative Assessment and prognostication of penile cancer: A Prospective Pilot Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094122
Enrollment
15
Registered
2025-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C608- Malignant neoplasm of overlappingsites of penis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

AIIMS Guwahati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with the diagnosis of carcinoma penis

Exclusion criteria

Exclusion criteria: Advanced disease not amenable to surgery, Metastatic disease

Design outcomes

Primary

MeasureTime frame
Concordance between findings of mpMRI without artificial erection and histopathological results, and the presence of lymph node metastases in PD L1 marker-positive casesTimepoint: Baseline, 3 months, 6 months, 9 months & 12 months—

Secondary

MeasureTime frame
Albumin-Alkaline phosphatase ratio in detecting Lymph node metastasesTimepoint: Baseline, 3 months, 6 months, 9 months & 12 months—

Countries

India

Contacts

Public ContactShitangsu Kakoti

All India Institute of Medical Sciences Guwahati

drshitangsu@gmail.com7002199137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026